| Name | Title | Contact Details |
|---|
DUAL North America is a prominent independent underwriting organization based in the United States, part of the global DUAL Group. Established in 2013, it has become a leading program administrator in the insurance sector. The company operates under the Howden-owned DUAL Group, which is recognized as one of the largest managing general agents worldwide, with a presence in 21 countries and over $3.5 billion in gross written premium. The company specializes in expert underwriting solutions across various insurance lines, including commercial property, casualty, financial lines, and surety. DUAL North America offers more than 40 unique products tailored to meet diverse client needs. It also features a robust online platform that enables appointed producers to quote, bind policies, and manage documents digitally. With a network of over 11,000 brokers globally, DUAL North America serves a wide range of clients, from small businesses to large fleets, particularly in regions like California and Texas.
Del Peterson & Associates was founded in 1972 by Del Peterson. During the early years we focused our efforts in the Fertilizer & Grain Industries and set the standard for professional onsite auctions in these respective fields. Since that time, Del has retired and his son, Steve Peterson, is now the President/CEO of the business. Del Peterson & Associates Auctioneers is dedicated to making your Online Auction experience the best possible. We specialize in selling equipment and facilities through our public Online Auction Service. This is quickly becoming the industry leader for buyers and sellers to get together to liquidate and expand their businesses. WHAT WE DO DPA Auctions is dedicated to making your Online Auction experience the best possible. We specialize in selling equipment and facilities through our public Online Auction Service. This is quickly becoming the industry leader for buyers and sellers to get together to liquidate and expand their businesses. We strive to maintain the true auction experience at the convenience of selling and bidding over the internet. We provide one of the easiest auction buying platforms. Our Live Auction Board provides the feel of an onsite auction with a dynamic clock, bidding extension time and the comfort and convenience of bidding from you own computer, tablet or smart phone. We have a multi-faceted national marketing program that has proven to be very effective in targeting clients across the United States. We have an experienced sales staff and provide additional marketing support through our website, sale bills, and advertising in respected regional and national publications. Our team of professionals is hard-working, honest, and reliable. Please consider how we can assist you in maximizing the value of the assets you desire to sell and/or provide you excellent values for the equipment and vehicles you wish to purchase. Put our 40 years of experience to work for you with our Selling Made Simple strategy!
Cameron Ashley Building Products is a prominent omni-channel distributor specializing in roofing, insulation, siding, gypsum, and other specialty building products. The company operates over 45 distribution centers across 26 states, providing more than 4.2 million square feet of storage space. Many of these centers are strategically located near major metropolitan areas, ensuring efficient product availability. The company serves over 5,000 customers in the lumber and building materials industry, including lumberyards, building materials suppliers, and contractors. Cameron Ashley combines distribution center operations with a direct-from-manufacturer approach to enhance supply chain management. This allows them to deliver a wide range of innovative products and services tailored to market needs. Cameron Ashley also fosters a supportive work environment, offering various employee benefits and development programs to prepare future leaders in the industry.
Insurance Quantified is a leading underwriting technology provider that arms commercial property and casualty insurance carriers and MGAs with the data and analytics they need to grow their business, improve underwriting profitability and be a preferred partner and employer. Backed by Two Sigma, a pioneer and global leader in the financial sciences, we believe that systematically delivering the right data to the right people at the right time will enable faster coverage decisions, more agile product innovation and significant risk reduction for all participants in the underwriting value chain. On June 20, 2023, Insurance Quantified acquired Groundspeed Analytics, the market leader in ingestion and data solutions to the commercial P&C industry. Together, the united technology capabilities, market success, and committed backing of Two Sigma creates an unparalleled underwriting technology partner for commercial insurers.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.